Role of SCH79797 in maintaining vascular integrity in rat model of subarachnoid hemorrhage

Stroke

Volumn 44, Issue 5, 2013, Pages 1410-1417

  Yan, Junhao ^a,b   Manaenko, Anatol ^b   Chen, Sheng ^b,d   Klebe, Damon ^b   Ma, Qingyi ^b   Caner, Basak ^b   Fujii, Mutsumi ^b   Zhou, Changman ^a   Zhang, John H ^b,c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^d THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

microvascular permeability; protease activated receptor 1; rat; subarachnoid hemorrhage; VE cadherin

Indexed keywords

1 AMINO 3 CYCLOPROPYLAMINO 7 (4 ISOPROPYLBENZYL) 7H PYRROLO[3,2 F]QUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ARGATROBAN; BETA ARRESTIN 2; FIBRONECTIN; P21 ACTIVATED KINASE 1; PROTEINASE ACTIVATED RECEPTOR 1; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING TIME; BLOOD BRAIN BARRIER; BRAIN WATER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; ENDOCYTOSIS; EXTRAVASATION; HIPPOCAMPUS; IMMUNOPRECIPITATION; LEFT HEMISPHERE; MALE; MORTALITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RIGHT HEMISPHERE; SUBARACHNOID HEMORRHAGE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DISULFIDES; ENZYME INHIBITORS; MALE; NAPHTHOLS; P21-ACTIVATED KINASES; PERMEABILITY; PYRROLES; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PAR-1; SUBARACHNOID HEMORRHAGE;

EID: 84876825168     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.678474     Document Type: Article

References (32)

1. Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke. 2002;33:1225-1232.
2. Yan J, Li L, Khatibi NH, Yang L, Wang K, Zhang W, et al. Blood-brain barrier disruption following subarchnoid hemorrhage may be faciliated through PUMA induction of endothelial cell apoptosis from the endo-plasmic reticulum. Exp Neurol. 2011;230:240-247.
3. Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol. 2010;72:463-493.
4. Yan J, Chen C, Hu Q, Yang X, Lei J, Yang L, et al. The role of p53 in brain edema after 24 h of experimental subarachnoid hemorrhage in a rat model. Exp Neurol. 2008;214:37-46.
5. Wallez Y, Huber P. Endothelial adherens and tight junctions in vascular homeostasis, infammation and angiogenesis. Biochim Biophys Acta. 2008;1778:794-809.
6. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, et al. Vascular endothelial-cadherin is an important determinant of micro-vascular integrity in vivo. Proc Natl Acad Sci USA. 1999;96:9815-9820.
7. Saito T, Bunnett NW. Protease-activated receptors: regulation of neuro-nal function. Neuromolecular Med. 2005;7:79-99.
8. Lang NN, Gumundsdóttir IJ, Newby DE. Vascular PAR-1: activity and antagonism. Cardiovasc Ther. 2011;29:349-361.
9. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006;8:1223-1234.
10. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological defcits. J Neurosurg. 1997;86:594-602.
11. Nina P, Schisano G, Chiappetta F, Luisa Papa M, Maddaloni E, Brunori A, et al. A study of blood coagulation and fbrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with Hunt-Hess grade and outcome. Surg Neurol. 2001;55:197-203.
12. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Hemostasis in spontaneous subarachnoid hemorrhage. Neurosurgery. 1995;37:226-234.
13. Kai Y, Hirano K, Maeda Y, Nishimura J, Sasaki T, Kanaide H. Prevention of the hypercontractile response to thrombin by proteinase-activated receptor-1 antagonist in subarachnoid hemorrhage. Stroke. 2007;38:3259-3265.
14. Bederson JB, Germano IM, Guarino L. Cortical blood fow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke. 1995;26:1086-91; discussion 1091.
15. Chintala MS, Chiu PJ, Bernadino V, Tetzloff GG, Tedesco R, Sabin C, et al. Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats. Eur J Pharmacol. 1998;349:237-243.
16. Hwa JJ, Ghibaudi L, Williams P, Chintala M, Zhang R, Chatterjee M, et al. Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ Res. 1996;78:581-588.
17. Sugawara T, Ayer R, Jadhav V, Zhang JH. A new grading system evaluating bleeding scale in flament perforation subarachnoid hemorrhage rat model. J Neurosci Methods. 2008;167:327-334.
18. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological defcit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995;26:627-34; discussion 635.
19. Arruzazabala ML, Molina V, Carbajal D, Más R. D-003 and warfarin interaction on the bleeding time and venous thrombosis experimentally induced in rats. J Med Food. 2004;7:260-263.
20. Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sugita M. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fuorescence. J Cereb Blood Flow Metab. 1988;8:282-284.
21. Yeung D, Manias JL, Stewart DJ, Nag S. Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown. Acta Neuropathol. 2008;115:635-642.
22. Ohyama H, Hosomi N, Takahashi T, Mizushige K, Kohno M. Thrombin inhibition attenuates neurodegeneration and cerebral edema formation following transient forebrain ischemia. Brain Res. 2001;902: 264-271.
23. Nagatsuna T, Nomura S, Suehiro E, Fujisawa H, Koizumi H, Suzuki M. Systemic administration of argatroban reduces secondary brain damage in a rat model of intracerebral hemorrhage: histopathological assessment. Cerebrovasc Dis. 2005;19:192-200.
24. Létienne R, Leparq-Panissié A, Bocquet A, Calmettes Y, Culié C, Le Grand B. PAR1 antagonist mediated antithrombotic activity in extracorporeal arterio-venous shunt in the rat. Thromb Res. 2010;125: 257-261.
25. Perez M, Lamothe M, Maraval C, Mirabel E, Loubat C, Planty B, et al. Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo. J Med Chem. 2009;52:5826-5836.
26. Paing MM, Johnston CA, Siderovski DP, Trejo J. Clathrin adaptor AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization. Mol Cell Biol. 2006;26:3231-3242.
27. Trejo J, Altschuler Y, Fu HW, Mostov KE, Coughlin SR. Protease-activated receptor-1 down-regulation: a mutant HeLa cell line suggests novel requirements for PAR1 phosphorylation and recruitment to clath-rin-coated pits. J Biol Chem. 2000;275:31255-31265.
28. Wollny T, Iacoviello L, Buczko W, de Gaetano G, Donati MB. Prolongation of bleeding time by acute hemolysis in rats: a role for nitric oxide. Am J Physiol. 1997;272:H2875-H2884.
29. Nadal-Wollbold F, Bocquet A, Bourbon T, Létienne R, Le Grand B. Protease-activated receptor 1 antagonists prevent platelet aggregation and adhesion without affecting thrombin time. Eur J Pharmacol. 2010;644:188-194.
30. Dejana E, Orsenigo F, Molendini C, Baluk P, McDonald DM. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res. 2009;335:17-25.
31. Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell. 2009;16:209-221.
32. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 1996;84:345-357.